FDA NDC Directory · JSON-LD · Markdown

Mesalamine

NDC 63304-175 · HUMAN PRESCRIPTION DRUG · TABLET, DELAYED RELEASE

Labeler / ManufacturerSun Pharmaceutical Industries, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA211858
Dosage form / routeTABLET, DELAYED RELEASE · ORAL
Active ingredientsMESALAMINE (1.2 g/1)
Marketing started20190201
Package count1

External sources

Source: openFDA. Public-domain (CC0).